Search research articles
Contact Us
Filters
Showing results (431-440 of 600) with videos related to
Page
of 60
Sort By:
Ebiomedicine
|
July 28, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
Clara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, et al.
JMIR Public Health and Surveillance
|
September 24, 2024
Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis
Jorge J Cabrera Alvargonzalez, Ana Larrañaga, Javier Martinez, et al.
Journal of Medical Virology
|
July 21, 2005
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
Berta Rodes, Federico García, Carolina Gutierrez, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 25, 2018
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
Janine R Danko, Tadeusz Kochel, Nimfa Teneza-Mora, et al.
Clinical Immunology (Orlando, Fla.)
|
September 1, 2020
Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients
María Caridad Montalvo Villalba, Odalys Valdés Ramírez, Mayra Muné Jiménez, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 25, 2019
Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU): Part 1: Background, approach, and summary of findings
Liam Simms, Anna Clarke, Thilo Paschke, et al.
The Journal of Antimicrobial Chemotherapy
|
October 14, 2011
A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors
Maria José Buzon, Itziar Erkizia, Christian Pou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma
Regina Alemany, David S Moura, Andres Redondo, et al.
The Journal of Infectious Diseases
|
July 3, 2023
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy
Silvia Bernal, Maria C Puertas, Sara Morón-López, et al.
Chemistry & Biology
|
July 28, 2010
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains
Catarina R Vieira, Jose M Munoz-Olaya, Jesús Sot, et al.
Page
of 60
Search research articles
Search
Showing results (431-440 of 600) with videos related to
Sort By:
Page
of 60
Ebiomedicine
|
July 28, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
Clara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, et al.
JMIR Public Health and Surveillance
|
September 24, 2024
Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis
Jorge J Cabrera Alvargonzalez, Ana Larrañaga, Javier Martinez, et al.
Journal of Medical Virology
|
July 21, 2005
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
Berta Rodes, Federico García, Carolina Gutierrez, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 25, 2018
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
Janine R Danko, Tadeusz Kochel, Nimfa Teneza-Mora, et al.
Clinical Immunology (Orlando, Fla.)
|
September 1, 2020
Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients
María Caridad Montalvo Villalba, Odalys Valdés Ramírez, Mayra Muné Jiménez, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 25, 2019
Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU): Part 1: Background, approach, and summary of findings
Liam Simms, Anna Clarke, Thilo Paschke, et al.
The Journal of Antimicrobial Chemotherapy
|
October 14, 2011
A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors
Maria José Buzon, Itziar Erkizia, Christian Pou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma
Regina Alemany, David S Moura, Andres Redondo, et al.
The Journal of Infectious Diseases
|
July 3, 2023
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy
Silvia Bernal, Maria C Puertas, Sara Morón-López, et al.
Chemistry & Biology
|
July 28, 2010
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains
Catarina R Vieira, Jose M Munoz-Olaya, Jesús Sot, et al.
Page
of 60